Abstract:Currently, multi-drug resistance (MDR) to antineoplastic drugs is a major obstacle to successful treatment of carcinoma. Looking for novel agents with anti-MDR activity is an effectively way to overcome cancer drug resistance. Our previous study showed that podophyllotoxin derivative exhibited potent anti-proliferative effect and down-regulated the expression level of P-gp in K562/ADR cells, which probably was related with the MAPK pathways. However, the relation of P-gp expression and MAPK pathways still remains unclear. In this study, a series of aromatic heterocyclic esters of podophyllotoxin were synthesized and their anticancer effects were evaluated against two human chronic myeloid leukemia cell lines (K562 and K562/ADR), simultaneously, the initial structure-activity relationship was summarized. The most potent compound, Z5, displayed an IC50 value of 0.032 ± 0.006 μM against K562/ADR cells, with a lower resistant factor value of 1.280. Treatment of K562/ADR cells with Z5 caused S cell cycle arrest through reductions in cyclinA, cyclinB1, CDK1 and CDK2 levels. Moreover, Z5 treatment resulted in the induction of apoptosis as characterized by DNA staining, flow cytometry analysis and cleavage of procaspases-3, -8, -9 and PARP. Notably, Z5 significantly inhibited P-gp expression in K562/ADR cells. Additionally, Z5 also caused reactive oxygen species (ROS) generation, which was further demonstrated by preincubation with the antioxidant N-acetylcysteine (NAC). Western blotting revealed that Z5 markedly stimulated the MAPK pathways, including ERK1/2, JNK and P38, however, the mechanisms were prevented by NAC. Finally, the employment of NAC and MAPK inhibitors (U0126, SP600125 and SB203580) remarkably blocked the S phase arrest, apoptosis and down-regulation of P-gp induced by Z5. Taken together, Z5 strongly possessed the potential anti-MDR activity in K562/ADR cells through ROS/MAPK pathways-dependent S phase arrest, apoptosis and down-regulation of P-gp expression.

Design, Synthesis and Antineoplastic Activity of Novel Hybrids of Podophyllotoxin and Indirubin Against Human Leukaemia Cancer Cells As Multifunctional Anti-Mdr Agents.

Novel SAHA-bendamustine hybrid NL-101 in combination with daunorubicin synergistically suppresses acute myeloid leukemia

Synthesis and Evaluation of Novel Podophyllotoxin Derivatives As Potential Antitumor Agents.

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Design, Synthesis and Biological Evaluation of Novel Nitric Oxide-Donating Podophyllotoxin Derivatives As Potential Antiproliferative Agents Against Multi-Drug Resistant Leukemia Cells

Synthesis, Antitumor Evaluation and Molecular Docking Study of a Novel Podophyllotoxin-Lonidamine Hybrid

Design, Synthesis, and Biological Evaluation of Indole Carboxylic Acid Esters of Podophyllotoxin As Antiproliferative Agents

Synthesis And Evaluation Of New Podophyllotoxin Derivatives With In Vitro Anticancer Activity

Design, Synthesis and Evaluation of the Multidrug Resistance-Reversing Activity of Pyridine Acid Esters of Podophyllotoxin in Human Leukemia Cells

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Potential anti-MDR agents based on the podophyllotoxin scaffold: synthesis and antiproliferative activity evaluation against chronic myeloid leukemia cells by activating MAPK signaling pathways

Synthesis and Biological Evaluation of Novel Podophyllotoxin-Nsaids Conjugates As Multifunctional Anti-Mdr Agents Against Resistant Human Hepatocellular Carcinoma Bel-7402/5-FU Cells

Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds

Design, Synthesis and Antitubulin Activity of Novel Podophyllotoxin Derivatives As Potent Anticancer Agent

Aromatic Heterocyclic Esters of Podophyllotoxin Exert Anti-Mdr Activity in Human Leukemia K562/ADR Cells Via ROS/MAPK Signaling Pathways

Antimultidrug-Resistant Effect and Mechanism of A Novel Ca-4 Analogue Mz3 on Leukemia Cells

Synthesis of a dual functional anti-MDR tumor agent PH II-7 with elucidations of anti-tumor effects and mechanisms.

Novel Indole-Guanidine Hybrids As Potential Anticancer Agents: Design, Synthesis and Biological Evaluation

Synthesis and Antitumor Activity of Novel Podophyllotoxin Derivatives Against Multidrug-Resistant Cancer Cells

A Novel SAHA-bendamustine Hybrid Induces Apoptosis of Leukemia Cells

Design, Synthesis and Biological Evaluation of Biaryl Amide Derivatives As Modulators of Multi-Drug Resistance